PRKG1 and cystic fibrosis: As we did not detect significant differences between genotypes, we conclude that the effects of cGKI on the pro-fibrotic gene expression profile contribute to a lesser extent than the effects of the pathway on the proliferative behavior of CF/CMF (Figure 4C and D and Supplementary Figure S6E) to the observed in vivo phenotype.